SCHEMBL29359388

SCHEMBL29359388

Nc1ncnc2c1nc(Br)n2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 13/20 1.00
▸ PDE4B Q07343 13/20 1.00
▸ PDE4C Q08493 13/20 1.00
▸ PDE4D Q08499 13/20 1.00
▸ LMNA P02545 2/20 0.81
▸ RAPGEF3 O95398 1/20 0.81
▸ TSHR P16473 1/20 0.81
▸ HIF1A Q16665 1/20 0.81
▸ MAPT P10636 1/20 0.81
▸ PMP22 Q01453 1/20 0.81
▸ NPSR1 Q6W5P4 1/20 0.81
▸ PRKACA P17612 1/20 0.70
▸ PRKACG P22612 1/20 0.70
▸ PRKACB P22694 1/20 0.70
▸ STING1 Q86WV6 2/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2713659 1.00 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DLMNA
SCHEMBL29384358 1.00 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DLMNA
SCHEMBL5951342 1.00 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DLMNA
SCHEMBL13300468 1.00 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DLMNA
SCHEMBL16079734 1.00 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DLMNA
SCHEMBL9702440 0.90 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DLMNA
SCHEMBL13300472 0.90 PDE4A (0.81) PDE4APDE4BPDE4CPDE4DLMNA
SCHEMBL15906331 0.90 PDE4A (0.81) PDE4APDE4BPDE4CPDE4DLMNA
SCHEMBL29381703 0.90 RAPGEF3 (1.00) PDE4APDE4BPDE4CPDE4DLMNA
SCHEMBL1106661 0.90 PDE4A (0.81) PDE4APDE4BPDE4CPDE4DLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122038274-A Method for inducing differentiation and maturation of alveolar organoids and application thereof 广州国家实验室 2026-05-15 — — CN claimed
US-20260125650-A1 METHODS AND COMPOSITIONS FOR GENERATING HEPATOCYTES TRAILHEAD BIOSYSTEMS INC (US) 2026-05-07 — — US claimed
EP-4680726-A2 STEM CELL AND ORGANOID BASED METHODS FOR DIAGNOSTICS AND OPTIMIZATION OF EMBRYO IMPLANTATION Simbryo Technologies, Inc. (US) 2026-01-21 — — EP claimed
US-20250304916-A1 METHODS AND COMPOSITIONS FOR GENERATING VASCULAR LEPTOMENINGEAL CELLS TRAILHEAD BIOSYSTEMS INC (US) 2025-10-02 — — US claimed
EP-4605517-A1 AN IN VITRO METHOD FOR PRODUCING A 3D-STRUCTURE OF CELLS Universiteit Maastricht (NL) 2025-08-27 — — EP claimed
US-20250263669-A1 INDUCED TOTIPOTENT STEM CELLS AND PREPARATION METHOD THEREFOR UNIV TSINGHUA (CN) 2025-08-21 — — US claimed
CN-120192914-A Blood sinus networked liver organoid construction method and application 淇嘉科技(苏州)有限公司 2025-06-24 — — CN claimed
CN-119875992-A Culture system for generating alveolar organoids with alveolar sac morphology based on adult lung stem cells and application of culture system 中国医学科学院生物医学工程研究所 2025-04-25 — — CN claimed
CN-119875991-A Lung airway organoid culture system with tracheal branch morphological structure, application thereof and culture method 中国医学科学院生物医学工程研究所 2025-04-25 — — CN claimed
EP-4536806-A2 GENERATION OF LUNG ORGANOIDS FROM PLURIPOTENT STEM CELLS AND USE THEREOF The Trustees Of Columbia University In The City Of New York (US) 2025-04-16 — — EP claimed
CN-114181893-B Method for maturing liver double-phenotype cell 天津外泌体科技有限公司 2022-09-13 — — CN claimed
CN-111004770-B Functional hepatocyte induction method and special three-dimensional induction culture medium and application thereof 中国人民解放军军事科学院军事医学研究院 2022-08-23 — — CN claimed
WO-2022168908-A1 PRODUCTION METHOD FOR INTESTINAL TRACT CELLS DERIVED FROM PLURIPOTENT STEM CELLS AND HAVING CRYPT-VILLUS-LIKE STRUCTURES, AND USE THEREOF 公立大学法人名古屋市立大学 2022-08-11 — — WO claimed
US-20220186189-A1 METHOD FOR INDUCING DIFFERENTIATION OF ALVEOLAR EPITHELIAL CELLS KYOTO UNIVERSITY (JP) 2022-06-16 — — US claimed
WO-2022114937-A1 DECM EXTRACTED FROM HUMAN LUNG TISSUE AND LUNG ORGANOID CONSTRUCTION METHOD USING SAME 가톨릭대학교 산학협력단 2022-06-02 — — WO claimed
CN-114149961-B Multi-lineage liver organoid and construction method and application thereof 天九再生医学(天津)科技有限公司 2022-04-22 — — CN claimed
US-11299712-B2 Method for inducing differentiation of alveolar epithelial cells KYOTO UNIVERSITY (JP) 2022-04-12 — — US claimed
CN-114181893-A Method for maturing liver double-phenotype cell 天九再生医学(天津)科技有限公司 2022-03-15 — — CN claimed
CN-114149961-A Multi-lineage liver organoid and construction method and application thereof 天九再生医学(天津)科技有限公司 2022-03-08 — — CN claimed
US-20220025324-A1 METHODS OF PRODUCING VENOUS ANGIOBLASTS AND SINUSOIDAL ENDOTHELIAL CELL-LIKE CELLS AND COMPOSITIONS THEREOF UNIVERSITY HEALTH NETWORK (CA) 2022-01-27 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125650-A1 METHODS AND COMPOSITIONS FOR GENERATING HEPATOCYTES WNT3A, GSK3B, GSK3A PDE4A 1415/4885PDE4B 1268/4885PDE4C 2174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback